6 / 31
Page 28
Notes:
conferenceseries
.com
Volume 7, Issue 6 (Suppl)
J Alzheimers Dis Parkinsonism, an open access journal
ISSN: 2161-0460
Dementia 2017
October 16-18, 2017
ALZHEIMER’S DISEASE & DEMENTIA
October 16-18, 2017 | Rome, Italy
9
th
International Conference on
Unified theory of Alzheimer's disease: Evolution is the key to Alzheimer's prevention and early
treatment
Jennie Ann Freiman
Mount Sinai School of Medicine, USA
T
he Unified Theory of Alzheimer's Disease (UTAD) defines what drives Alzheimer's, bringing all known causal risk factors
into a logical, biological context which in turn provides an actionable prevention and early treatment strategy. UTAD
identifies five broad categories of contributing lifestyle factors, all of which are necessary for ongoing growth and function of
the hippocampal memory center. The specific lifestyle led by each person, each with a unique set of deficits, means there are as
many causes of Alzheimer's as there are lifestyles. Individual measures such as increasing exercise or adopting a Mediterranean
diet are minimally successful because they address only one aspect of the risk complex. Standard medications cannot
compensate for disease-causing deficiencies because a healthy lifestyle cannot be put in a pill. Likewise, clinical trials continue
to disappoint because they offer too little, too late, and treat symptoms and results of the disorder, rather than root causes.
Alzheimer's is preventable, and in its early stages, treatable, due to hippocampal neurogenesis and neuronal rejuvenation, but
only with a systematic approach. Through education and fundamental rethinking of what drives Alzheimer's, we can move
away from dependence on drug solutions to empowering healthy choices. UTAD rejects the conventional dogma that has
driven Alzheimer's research and treatment in favor of a doctrine based on evolutionary needs of the ancestral brain, which
dominated human history for almost 2 million years. UTAD was published by Dr. Michael Nehls in 2016 in the Journal of
Molecular Psychiatry and has been successfully adopted by medical practitioners.
Biography
Jennie Ann Freiman and Michael Nehls (Germany) are co-writing a book on UTAD for health practitioners who wish to incorporate the plan into their professional
practice, and for lay people proactive in their care. Freiman received her M.D from the Mount Sinai School of Medicine in NY. After a successful career in
gynecology, she launched Oobroo Inc, a wellness company, and writes and blogs on wellness issues. Prevention and early treatment of Alzheimer's disease is her
passion. Freiman has previously published in the New England Journal of Medicine and many lay publications.
DrFreiman@gmail.comJennie Ann Freiman, J Alzheimers Dis Parkinsonism 2017, 7:6(Suppl)
DOI: 10.4172/2161-0460-C1-033